Panobinostat in multiple myeloma

In this issue of The Lancet Haematology, Rakesh Popat and colleagues 1 Popat R Brown SR Flanagan L et al. Bortezomib, thalidomide, dexamethasone and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. Lancet Haematol. 2016; (published online Nov 11.)http://dx.doi.org/10.1016/S2352-3026(16)30165-X PubMed Google Scholar report on a four-drug combination of panobinostat, bortezomib,...